Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean Women
NCT ID: NCT07283107
Last Updated: 2025-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
8910 participants
INTERVENTIONAL
2025-11-17
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will enroll a total of 3000 never-screeners (600 participants in each arm) and 5910 recent screeners (1182 participants in each arm) across 5 intervention groups. Sample size calculations were performed to ensure 90% power at a two-sided significance level of 5% (α = 0.05) to detect a clinically meaningful difference in the primary outcome, defined as an absolute increase of 7% in mammogram uptake. The study employs a ≥"pick-the-winner" design, wherein each intervention arm (Arms 2-5) is compared individually against the control arm (Arm 1). An intervention will be considered successful if it demonstrates at least a 7% absolute improvement in uptake relative to the control.
Statistical analysis plan: Pairwise comparisons between each intervention arm (Arms 2-5) and the control arm (Arm 1) will be performed using logistic regression to estimate the odds ratios (ORs), absolute differences in proportions, and 95% confidence intervals (CIs) for mammogram uptake.
Primary endpoint: All data on mammogram completion will be obtained from existing sources such as electronic medical records and the national screening registry. The primary outcome is mammogram uptake within four months of the first intervention (date of sending the mailer/ push notification, whichever is later). Uptake data might be also extracted at the 6 and 12 month time-point to see if there was any additional uptake. These extended follow-up points will allow for the assessment of any delayed uptake, which may help to understand the longer-term impact of the interventions. No new clinical data will be generated from participants. Screening behavior will be assessed through electronic medical record (EMR) review, specifically from the National University Health System's (NUHS) mammography booking and screening databases (the national screening registry). Data extracted will include mammogram booking and attendance status, date of screening (if any), and relevant demographic details. All data on mammogram completion will be obtained from existing sources such as electronic medical records. Findings will provide evidence-based strategies to improve breast cancer screening participation, potentially reducing breast cancer mortality and informing future public health policy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm (Arm 1)
Does not receive any reminder to go for mammogram.
No interventions assigned to this group
Arm 2: : One mailed reminder
Receives a single mail reminder
Arm 2: One mailed reminder
Receives a mailed reminder with basic information about breast cancer and instructions on scheduling a mammogram
Arm 3: Two mailed reminders
Receives two mail reminders, 1 month apart
Arm 3: Two mailed reminders
Receives a mailed reminder + follow-up mailed reminder, 1 month after the first reminder
Arm 4: Mailed Reminder with Prescheduled Appointment
Recieves a mailed reminder with prescheduled appointment
Arm 4: Mailed reminder with prescheduled appointment
Receives one mailed reminder with a pre-scheduled appointment, with instructions to change appointment
Arm 5: Mailed reminder with enhanced messaging
Receives mailed reminder with enhanced messaging
Arm 5: Mailed reminder with enhanced messaging
Receives one mailed reminder with enhanced messaging motivating recipient to undergo screening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arm 2: One mailed reminder
Receives a mailed reminder with basic information about breast cancer and instructions on scheduling a mammogram
Arm 3: Two mailed reminders
Receives a mailed reminder + follow-up mailed reminder, 1 month after the first reminder
Arm 4: Mailed reminder with prescheduled appointment
Receives one mailed reminder with a pre-scheduled appointment, with instructions to change appointment
Arm 5: Mailed reminder with enhanced messaging
Receives one mailed reminder with enhanced messaging motivating recipient to undergo screening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 50-69
* Registered as a patient at the National University Hospital
* Registered and active user of NUHS App
* Signed up with Healthier SG with a primary care provider within the NUHS Primary Care Network
* For "never-screener" cohort: Must have never undergone mammogram screening
* For "repeat-screener" cohort : Must have completed screening in the last 18-24 months but have not booked their next appointment yet
Exclusion Criteria
* Mammogram done in the past 24 months in EPIC
50 Years
69 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University Hospital, Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soo-Chin Lee, MBBS, MRCP
Role: PRINCIPAL_INVESTIGATOR
National University Hospital Singapore, Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National University Hospital Singapore
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-0880
Identifier Type: -
Identifier Source: org_study_id